Implications and Future Directions for Octreotide Use in Angiodysplasia Management.

Jiang, Wei; Yang, Kaiqi; Shi, Haiyun

Jiang, Wei; Yang, Kaiqi; Shi, Haiyun.

Afiliação

Jiang W; Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University and, National Clinical Research Center for Digestive Diseases and, State Key Laboratory of Digestive Health and, Beijing Digestive Disease Center and, Beijing Key Laboratory for Precancerous Lesion of Digestive Diseases, Beijing, China.
Yang K; Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University and, National Clinical Research Center for Digestive Diseases and, State Key Laboratory of Digestive Health and, Beijing Digestive Disease Center and, Beijing Key Laboratory for Precancerous Lesion of Digestive Diseases, Beijing, China.
Shi H; Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University and, National Clinical Research Center for Digestive Diseases and, State Key Laboratory of Digestive Health and, Beijing Digestive Disease Center and, Beijing Key Laboratory for Precancerous Lesion of Digestive Diseases, Beijing, China.

Gastroenterology ; 167(5): 1051, 2024 Oct.

Article em En | MEDLINE | ID: mdl-38880213

Assuntos

Angiodisplasia; Octreotida; Humanos; Octreotida/uso terapêutico; Angiodisplasia/tratamento farmacológico; Angiodisplasia/complicações; Fármacos Gastrointestinais/uso terapêutico; Resultado do Tratamento; Hemorragia Gastrointestinal/etiologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Octreotida / Angiodisplasia Limite: Humans Idioma: En Revista: Gastroenterology Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google